# Kaggle Breast-Cancer Dataset Public Metadata and Eligibility Review

**Status:** Public-metadata-only review. Three user-supplied public dataset pages were inspected without downloading, opening, copying, or processing any underlying dataset assets. This record is not evidence of dataset quality, provenance, de-identification, consent, licensing sufficiency, privacy, clinical suitability, model utility, performance, deployment, or runtime behavior.

## Review outcome

All three candidates remain **ineligible for data use in this branch**. Public page visibility and a page-displayed license label are not sufficient to establish the authority, upstream rights, permitted purpose, data-protection posture, institutional approvals, source provenance, and research protocol necessary to access or use potentially sensitive medical research material.

| Candidate | Public-page observation | Data-use eligibility | Reason for closure |
|---|---|---|---|
| User-supplied candidate A | The page presents itself as an image-oriented breast-cancer resource and displays a non-commercial attribution/share-alike license label. | `ineligible_pending_primary_source_rights_and_governance` | Page-level terms and a stated source relationship do not establish the full upstream rights chain, permitted research use, or institutional data-governance decision. |
| User-supplied candidate B | The page presents a histopathology-oriented breast-cancer resource and displays no resolved license label. | `ineligible_license_unresolved` | An unresolved displayed license closes data-use eligibility before any asset may be accessed. |
| User-supplied candidate C | The page presents an image-oriented breast-cancer resource, displays a public-domain label, and describes transformed and cross-sourced material. | `ineligible_pending_primary_source_chain_and_governance` | A page-level public-domain label does not resolve the upstream source chain, transformation provenance, permitted purpose, or institutional data-governance decision. |

## What was and was not observed

The review observed public page titles, descriptions, and visible license or access presentation only. Download controls were visible on the inspected pages but were not used. No dataset archive, record, label, image, annotation, directory, manifest, metadata export, or account-restricted page was opened or retained. The public pages are identified in the pre-review plan; this review intentionally does not reproduce their locations or content. [1]

> **Interpretation rule:** A public listing is neither research authorization nor evidence that its underlying material may be downloaded, processed, trained on, shared, or used in a healthcare-related study.

## Independent data-use gate

Before any separate data-use activity can be considered, the responsible parties must independently establish the following matters. This is a governance checklist, not legal, ethics, privacy, medical, or institutional advice.

| Required gate | Minimum documented question |
|---|---|
| Authority and protocol | Who authorizes the intended study, and what narrowly prespecified research purpose, participants, outputs, and stop conditions apply? |
| Primary-source provenance | What is the original data source, what transformations or republications occurred, and what rights attach at each step? |
| License and permitted use | Does the actual rights holder permit the proposed access, study use, derivative work, sharing, reporting, and publication? |
| Data protection and ethics | Which institutional, legal, ethics, consent, de-identification, retention, access-control, and security requirements apply? |
| Technical isolation | How will approved data be held outside public documentation and outside the source-only Agent chain, with no inappropriate disclosure or cross-boundary transfer? |
| Analysis plan | What independent protocol defines the model, splits, evaluation, reporting, bias analysis, limitations, and reproducibility controls before work begins? |

## Retained boundaries

No dataset was downloaded or inspected. No Agent code, data connector, ingestion route, local dataset store, model, trainer, inference process, metric calculation, update, submission, aggregation path, deployment, or runtime operation was added. No claim is made about patient data, privacy outcome, clinical relevance, data quality, label validity, model performance, or operational readiness.

The completed synthetic marker-rejection chain remains unchanged and does not receive or process any dataset asset. The three data candidates remain ineligible until a separate data-use boundary is independently governed and evidenced.

## References

[1] [Kaggle breast-cancer dataset public metadata review plan](./KAGGLE_BREAST_CANCER_DATASET_PUBLIC_METADATA_REVIEW_PLAN.md)

[2] [Synthetic patient-data marker rejection chain completion audit](./SYNTHETIC_PATIENT_DATA_MARKER_REJECTION_CHAIN_COMPLETION_AUDIT.md)
